AstraZeneca’s antibody cocktail helps prevent COVID-19 for at least 6 months

A

AstraZeneca on Thursday cemented its lead in bringing a preventative COVID-19 shot to market, saying its antibody cocktail offered 83% protection over six months, providing another possible weapon in the fight against the pandemic.

The therapy, called AZD7442 or Evusheld, had previously been shown to confer 77% protection against symptomatic illness after three months, in an earlier readout of the late-stage PROVENT trial in August. read more

The data give hope of additional protection for people who do not respond well to vaccines, such as cancer patients.

The Anglo-Swedish company also said a separate study in patients with mild-to-moderate COVID-19 showed a higher dose of AZD7442 cut the risk of symptoms worsening by 88% when given within three days of the first symptoms.

https://www.reuters.com/business/healthcare-pharmaceuticals/astrazeneca-antibody-works-prevent-treat-covid-19-longer-term-studies-2021-11-18

By Justgivemepositivenews Team